FourThought Financial’s NeoGenomics NEO Stock Holding History

FourThought Financial’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$21K	Sell	2,489 -150	-6%	-$1.49K	﹤0.01%	849
2022 Q2	$22K	Hold	2,639	–	–	﹤0.01%	841
2022 Q1	$32K	Buy	2,639 +473	+22%	+$9.95K	﹤0.01%	792
2021 Q4	$74K	Hold	2,166	–	–	0.01%	552
2021 Q3	$104K	Buy	2,166 +68	+3%	+$3.15K	0.01%	478
2021 Q2	$94K	Sell	2,098 -83	-4%	-$3.68K	0.01%	518
2021 Q1	$105K	Sell	2,181 -192	-8%	-$10K	0.02%	479
2020 Q4	$127K	Buy	+2,373	New	+$107K	0.02%	429

Other funds holding NEO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FourThought Financial's NEO Position: Q3 2022 in Review

FourThought Financial reduced its NeoGenomics (NEO) stake by 5.7% in Q3 2022, selling an estimated $1.49K and leaving 2,489 shares worth $21K. The position accounts for ﹤0.01% of the portfolio, ranked #849.

FourThought Financial first reported a position in NEO in Q4 2020 and has held it in 8 quarters since. The position peaked at $127K in Q4 2020. 247 funds tracked by Wall St. Rank hold NEO as of Q3 2022.

FourThought Financial held 2,489 shares of NeoGenomics worth $21K as of Q3 2022.
FourThought Financial sold 150 NeoGenomics shares in Q3 2022, an estimated $1.49K.
NeoGenomics made up ﹤0.01% of FourThought Financial's portfolio in Q3 2022, its #849 holding.
FourThought Financial first reported a position in NeoGenomics in Q4 2020 and has held it in 8 quarters since.
FourThought Financial's NeoGenomics position peaked at $127K in Q4 2020.
247 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2022.

Based on FourThought Financial's 13F filing for Q3 2022, filed 21 Nov 2022.